Voogd J, Gerrits NM, Ruigrok TJH (1996) Organization of vestibulocerebellum. Ann NY Acad Sci 781:553–579
Article CAS PubMed Google Scholar
Farmer TW, Mustian VM (1963) Vestibulocerebellar ataxia. A newly defined hereditary syndrome with periodic manifestations. Arch Neurol 8:471–480
Article CAS PubMed Google Scholar
Choi KD, Choi K, Jen J et al (2017) Late-onset episodic ataxia associated with SLC1A3 mutation. J Hum Genet 62(3):443–446
Article CAS PubMed Google Scholar
Choquet K, La Piana R, Brais B (2015) A novel frameshift mutation in FGF14 causes an autosomal dominant episodic ataxia. Neurogenetics 16(3):233–236
Article CAS PubMed Google Scholar
Piarroux J, Riant F, Humbertclaude V et al (2020) FGF14-related episodic ataxia: delineating the phenotype of Episodic Ataxia type 9. Ann Clin Transl Neurol 7(4):565–572
Article CAS PubMed PubMed Central Google Scholar
Imbrici P, Eunson L, Graves T et al (2005) Late-onset episodic ataxia type 2 due to an-in-frame insertion in CACNA1A. Neurology 65:944–946
Article CAS PubMed Google Scholar
Cuenca-León E, Banchs I, Serra S et al (2009) Late-onset episodic ataxia type 2 associated with a novel loss-of-function mutation in the CACNA1A gene. J Neurol Sci 280:10–14
Julien J, Denier C, Ferrer X et al (2001) Sporadic late onset paroxysmal cerebellar ataxia in four unrelated patients: a new disease? J Neurol 248:209–221
Article CAS PubMed Google Scholar
Kerber KA, Jen JC, Perlman S, Baloh RW (2005) Late-onset pure cerebellar ataxia: differentiating those with and without identifiable mutations. J Neurol Sci 238(1–2):41–45
Article CAS PubMed Google Scholar
Jen JC, Wan J (2018) Handbook of clinical neurology. Episodic ataxias 155:205–215
Pellerin D, Danzi MC, Wilke C et al (2023) Deep intronic FGF14 GAA repeat expansion in late-onset cerebellar ataxia. N Engl J Med 388(2):128–141
Article CAS PubMed Google Scholar
Rafehi H, Read J, Szmulewicz DJ et al (2023) An intronic GAA repeat expansion in FGF14 causes the autosomal-dominant adult-onset ataxia SCA50/ATX-FGF14. Am J Hum Genet 110:105–119
Article CAS PubMed Google Scholar
Tinetti ME, Williams TF, Mayewski R (1986) Fall risk index for elderly patients based on number of chronic disabilities. Am J Medicine 80(3):429–434
Subramony SH, May W, Lynch D et al (2005) Measuring friedreich ataxia: interrater reliability of a neurologic rating scale. Neurology 64:1261–1262
Article CAS PubMed Google Scholar
Pujana MA, Corral J, Gratacos M et al (1999) Spinocerebellar ataxias in Spanish patients: genetic analysis of familial and sporadic cases: The Ataxia Study Group. Hum Genet 104:516–522
Article CAS PubMed Google Scholar
Cortese A, Simone R, Sullivan R et al (2019) Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia. Nat Genet 51:649–658
Article CAS PubMed PubMed Central Google Scholar
Browne DL, Gancher ST, Nutt JG et al (1994) Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat Genet 8:136–140
Article CAS PubMed Google Scholar
Ophoff RA, Terwindt GM, Vergouwe MN et al (1996) Familial hemiplegic migraine and episodic ataxia type 2, are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87:543–552
Article CAS PubMed Google Scholar
Escayg A, De Waard M, Lee D et al (2000) Coding and noncoding variation of the human calcium-channel b 4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia. Am J Hum Genet 66:1531–1539
Article CAS PubMed PubMed Central Google Scholar
Jen J, Wan J, Palos TP et al (2005) Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures. Neurology 65:529–534
Article CAS PubMed Google Scholar
Bonnet C, Pellerin D, Roth V et al (2023) Optimized testing strategy for the diagnosis of GAA-FGF14 ataxia/spinocerebellar ataxia 27B. Sci Rep 13:9737
Article CAS PubMed PubMed Central Google Scholar
Lossos A, Meiner Z, Barash V et al (1998) Adult polyglucosan body disease in Ashkenazi Jewish patients carrying the Tyr329Ser mutation in the glycogen-branching enzyme gene. Ann Neurol 44:867–872
Article CAS PubMed Google Scholar
Alvarez-Mora MI, Rodríguez-Revenga L, Jodar M et al (2023) Implementation of exome sequencing in clinical practice for neurological disorders. Genes (Basel) 14(4):813
Article CAS PubMed Google Scholar
National Center for Biotechnology Information. ClinVar; [VCV000195573.21], https://www.ncbi.nlm.nih.gov/clinvar/variation/VCV000195573.21
National Center for Biotechnology Information. ClinVar; [VCV000195470.13]. https://www.ncbi.nlm.nih.gov/clinvar/variation/VCV000195470.13
Paradas C, Akman HO, Ionete C et al (2014) Branching enzyme deficiency: expanding the clinical spectrum. JAMA Neurol 71(1):41–47
Article PubMed PubMed Central Google Scholar
Zasorin NL, Baloh RW, Myers LB (1983) Acetazolamide-responsive episodic ataxia syndrome. Neurology 33(9):1212–1214
Article CAS PubMed Google Scholar
Ashton C, Indelicato E, Pellerin D et al (2023) Spinocerebellar ataxia 27B: episodic symptoms and acetazolamide response in 34 patients. Brain Commun. 5(5):fcad239
Article PubMed PubMed Central Google Scholar
Strupp M, Kalla R, Glasauer S et al (2008) Aminopyridines for the treatment of cerebellar and ocular motor disorders. Prog Brain Res 171:535–554
Wilke C, Pellerin D, Mengel D et al (2023) GAA-FGF14 ataxia (SCA27B): phenotypic profile, natural history progression and 4-aminopyridine treatment response. Brain 146(10):4144–4157
Pellerin D, Heindl F, Wilke C et al (2023) Intronic FGF14 GAA repeat expansions are a common cause of downbeat nystagmus syndromes: frequency, phenotypic profile, and 4-aminopyridine treatment response. medRxiv. https://doi.org/10.1101/2023.07.30.23293380
Comments (0)